A complete application in a minute
Tailored resume and cover letter, ready to send.
Lyell Immunopharma seeks a Senior Director of Manufacturing to lead the transition from clinical-stage to commercial cell therapy production. This role owns GMP manufacturing execution across the product lifecycle, including facility and process readiness for BLA submission and PLI, and building a scalable, inspection-ready commercial organization.
The position is hands-on and requires experience taking autologous cell therapy through late-stage manufacturing to licensure, with cross-functional
Using living cells to treat - and sometimes even cure - cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. And for patients with hematologic malignancies, there is a need for next-generation cell therapies that can deliver increased response rates and longer duration of response. We are a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell's product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.
The Senior Director of Manufacturing leads our cell therapy manufacturing organization through the transition from clinical-stage to commercial operations. The Senior Director owns GMP manufacturing execution across the product lifecycle, including facility and process readiness for BLA submission and pre-license inspection (PLI), and the build of a scalable, inspection-ready commercial manufacturing organization. This is a hands‑on leadership role for someone who has taken an autologous cell therapy through late-stage clinical manufacturing and into licensure and launch.
Strong scientific background and expertise in cell culture products - prior experience in cell or tissue therapy
Demonstrated experience in process characterization and product development, technology transfer, continuous improvement and change management